XRAY vs EXPD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 01, 2026
XRAY
EXPD
Investment Advisor Scores
EXPD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XRAY | EXPD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.3291 | 24.4499 | XRAY |
| PEG Ratio | 0.633 | 2.9782 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.1% | 32.1% | EXPD |
| Earnings Growth | 15.2% | 51.5% | EXPD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.3/100 | 62.4/100 | EXPD |
| Profit Margin | -15.0% | 7.6% | EXPD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XRAY
MarkdownPrice below a falling SMA50 (slope -7.5%), weak momentum, RSI 28
EXPD
MarkupPrice above SMA50, rising 50-day trend (4.1% over 20 days), RSI 51
Fundamentals Snapshot
| Metric | XRAY | EXPD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 5.8 | 23.2 |
| Trailing P/E | — | 27.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | 0.5% | 0.1% |
| Operating Margin | 0.1% | 0.1% |
| EPS | -2.69 | 6.74 |
| Dividend Yield | 0.04% | 0.01% |